Related Experiment Video

Updated: May 9, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Knockdown of ECHS1 protein expression inhibits hepatocellular carcinoma cell proliferation via suppression of Akt

Xiao-san Zhu1, Yi-chen Dai, Zhang-xing Chen

  • 1Department of Gastroenterology, the Chenggong Hospital Affiliated to Xiamen University, Wenyuan Road, Xiamen, Fujian 361003, China.

Critical Reviews in Eukaryotic Gene Expression
|July 25, 2013
PubMed

Insights

Echinase 1 (ECHS1) overexpression drives hepatocellular carcinoma (HCC) growth. Inhibiting ECHS1 with shRNA reduced tumor progression and enhanced chemotherapy effectiveness, suggesting ECHS1 as a potential HCC therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Echinase 1 (ECHS1) is overexpressed in various cancers, including hepatocellular carcinoma (HCC).
  • ECHS1 exhibits oncogenic activity, contributing to cancer progression.
  • The specific role of ECHS1 in HCC development requires further investigation.

Purpose of the Study:

  • To investigate the effect of ECHS1 knockdown on HCC growth.
  • To determine the impact of ECHS1 inhibition on HCC cell viability and apoptosis.
  • To explore the molecular mechanisms underlying ECHS1's role in HCC.

Main Methods:

  • ECHS1 knockdown was achieved using ECHS1 shRNA in HepG2 cells.
  • Cell viability and cisplatin-induced apoptosis were assessed.
  • Western blotting was used to analyze Akt activation and cell cycle-related gene expression.
  • Tumor xenograft mouse models were employed to evaluate ECHS1's in vivo effect.

Main Results:

  • ECHS1 shRNA effectively suppressed ECHS1 protein expression in HCC cells.
  • ECHS1 knockdown reduced HCC cell viability and enhanced cisplatin-induced apoptosis.
  • Akt activation and cell cycle-related gene expression were inhibited by ECHS1 knockdown.
  • ECHS1 inhibition suppressed HCC tumor growth in vivo.

Conclusions:

  • ECHS1 plays a significant role in HCC progression.
  • ECHS1 knockdown demonstrates therapeutic potential for HCC treatment.
  • Targeting ECHS1 with shRNA warrants further evaluation as a novel strategy for HCC control.

More Related Videos

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis07:26

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...